GO:0030529 | ribonucleoprotein complex | 2.11e-07 | 2.06e-03 | 5.130 | 5 | 5 | 82 |
GO:0000398 | mRNA splicing, via spliceosome | 1.95e-06 | 1.91e-02 | 4.488 | 5 | 15 | 128 |
GO:0003723 | RNA binding | 2.41e-06 | 2.36e-02 | 3.803 | 6 | 22 | 247 |
GO:0003747 | translation release factor activity | 2.85e-06 | 2.79e-02 | 9.166 | 2 | 2 | 2 |
GO:0008380 | RNA splicing | 6.81e-06 | 6.65e-02 | 4.122 | 5 | 21 | 165 |
GO:0097452 | GAIT complex | 1.71e-05 | 1.67e-01 | 8.166 | 2 | 2 | 4 |
GO:0031124 | mRNA 3'-end processing | 2.77e-05 | 2.71e-01 | 5.622 | 3 | 4 | 35 |
GO:0070934 | CRD-mediated mRNA stabilization | 2.84e-05 | 2.78e-01 | 7.844 | 2 | 2 | 5 |
GO:0006369 | termination of RNA polymerase II transcription | 3.56e-05 | 3.48e-01 | 5.503 | 3 | 5 | 38 |
GO:0070937 | CRD-mediated mRNA stability complex | 4.26e-05 | 4.16e-01 | 7.581 | 2 | 2 | 6 |
GO:0006379 | mRNA cleavage | 1.02e-04 | 9.96e-01 | 6.996 | 2 | 2 | 9 |
GO:0006479 | protein methylation | 1.55e-04 | 1.00e+00 | 6.707 | 2 | 2 | 11 |
GO:0010467 | gene expression | 1.94e-04 | 1.00e+00 | 2.688 | 6 | 49 | 535 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 3.83e-04 | 1.00e+00 | 4.359 | 3 | 5 | 84 |
GO:0071346 | cellular response to interferon-gamma | 5.32e-04 | 1.00e+00 | 5.844 | 2 | 2 | 20 |
GO:0017148 | negative regulation of translation | 1.46e-03 | 1.00e+00 | 5.122 | 2 | 5 | 33 |
GO:0048022 | negative regulation of melanin biosynthetic process | 1.74e-03 | 1.00e+00 | 9.166 | 1 | 1 | 1 |
GO:0016149 | translation release factor activity, codon specific | 1.74e-03 | 1.00e+00 | 9.166 | 1 | 1 | 1 |
GO:0016300 | tRNA (uracil) methyltransferase activity | 1.74e-03 | 1.00e+00 | 9.166 | 1 | 1 | 1 |
GO:0008609 | alkylglycerone-phosphate synthase activity | 1.74e-03 | 1.00e+00 | 9.166 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 1.74e-03 | 1.00e+00 | 9.166 | 1 | 1 | 1 |
GO:0001554 | luteolysis | 1.74e-03 | 1.00e+00 | 9.166 | 1 | 1 | 1 |
GO:0006396 | RNA processing | 2.14e-03 | 1.00e+00 | 4.844 | 2 | 4 | 40 |
GO:0006406 | mRNA export from nucleus | 2.59e-03 | 1.00e+00 | 4.707 | 2 | 7 | 44 |
GO:1901888 | regulation of cell junction assembly | 3.48e-03 | 1.00e+00 | 8.166 | 1 | 1 | 2 |
GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway | 3.48e-03 | 1.00e+00 | 8.166 | 1 | 1 | 2 |
GO:0006433 | prolyl-tRNA aminoacylation | 3.48e-03 | 1.00e+00 | 8.166 | 1 | 1 | 2 |
GO:0004818 | glutamate-tRNA ligase activity | 3.48e-03 | 1.00e+00 | 8.166 | 1 | 1 | 2 |
GO:0004827 | proline-tRNA ligase activity | 3.48e-03 | 1.00e+00 | 8.166 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 3.48e-03 | 1.00e+00 | 8.166 | 1 | 1 | 2 |
GO:0008611 | ether lipid biosynthetic process | 3.48e-03 | 1.00e+00 | 8.166 | 1 | 1 | 2 |
GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway | 3.48e-03 | 1.00e+00 | 8.166 | 1 | 1 | 2 |
GO:0006424 | glutamyl-tRNA aminoacylation | 3.48e-03 | 1.00e+00 | 8.166 | 1 | 1 | 2 |
GO:0005515 | protein binding | 4.45e-03 | 1.00e+00 | 0.857 | 13 | 198 | 4124 |
GO:0071013 | catalytic step 2 spliceosome | 4.91e-03 | 1.00e+00 | 4.235 | 2 | 5 | 61 |
GO:0008762 | UDP-N-acetylmuramate dehydrogenase activity | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:0036123 | histone H3-K9 dimethylation | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:0050774 | negative regulation of dendrite morphogenesis | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:0046582 | Rap GTPase activator activity | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:0005088 | Ras guanyl-nucleotide exchange factor activity | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:2000670 | positive regulation of dendritic cell apoptotic process | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:0002098 | tRNA wobble uridine modification | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:0017034 | Rap guanyl-nucleotide exchange factor activity | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:0031697 | beta-1 adrenergic receptor binding | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:0006415 | translational termination | 5.23e-03 | 1.00e+00 | 4.189 | 2 | 2 | 63 |
GO:0003407 | neural retina development | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 2 | 4 |
GO:0045292 | mRNA cis splicing, via spliceosome | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:0004652 | polynucleotide adenylyltransferase activity | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:0006449 | regulation of translational termination | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:0000055 | ribosomal large subunit export from nucleus | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:2000481 | positive regulation of cAMP-dependent protein kinase activity | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:0006333 | chromatin assembly or disassembly | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:0036124 | histone H3-K9 trimethylation | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 2 | 4 |
GO:0043631 | RNA polyadenylation | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:0035613 | RNA stem-loop binding | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:0001649 | osteoblast differentiation | 7.16e-03 | 1.00e+00 | 3.956 | 2 | 5 | 74 |
GO:0004521 | endoribonuclease activity | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0008610 | lipid biosynthetic process | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0038180 | nerve growth factor signaling pathway | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0021884 | forebrain neuron development | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0044822 | poly(A) RNA binding | 9.76e-03 | 1.00e+00 | 1.846 | 5 | 45 | 799 |
GO:0042754 | negative regulation of circadian rhythm | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 2 | 6 |
GO:0071321 | cellular response to cGMP | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 6 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 6 |
GO:2001224 | positive regulation of neuron migration | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 6 |
GO:0035234 | ectopic germ cell programmed cell death | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 6 |
GO:0019992 | diacylglycerol binding | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 6 |
GO:0002199 | zona pellucida receptor complex | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 4 | 7 |
GO:0007140 | male meiosis | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 7 |
GO:0032854 | positive regulation of Rap GTPase activity | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 7 |
GO:0008409 | 5'-3' exonuclease activity | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 2 | 7 |
GO:2001214 | positive regulation of vasculogenesis | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 2 | 7 |
GO:0000339 | RNA cap binding | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 4 | 7 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 7 |
GO:0032486 | Rap protein signal transduction | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 7 |
GO:0016020 | membrane | 1.30e-02 | 1.00e+00 | 1.514 | 6 | 56 | 1207 |
GO:0030553 | cGMP binding | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 1 | 8 |
GO:0005845 | mRNA cap binding complex | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 1 | 8 |
GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 1 | 8 |
GO:0071949 | FAD binding | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 1 | 8 |
GO:0005654 | nucleoplasm | 1.43e-02 | 1.00e+00 | 1.713 | 5 | 68 | 876 |
GO:0030488 | tRNA methylation | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 2 | 9 |
GO:0021591 | ventricular system development | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 1 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 3 | 9 |
GO:0008143 | poly(A) binding | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 2 | 10 |
GO:0061028 | establishment of endothelial barrier | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 1 | 10 |
GO:0042273 | ribosomal large subunit biogenesis | 1.90e-02 | 1.00e+00 | 5.707 | 1 | 1 | 11 |
GO:0043950 | positive regulation of cAMP-mediated signaling | 1.90e-02 | 1.00e+00 | 5.707 | 1 | 1 | 11 |
GO:0008334 | histone mRNA metabolic process | 1.90e-02 | 1.00e+00 | 5.707 | 1 | 1 | 11 |
GO:0045807 | positive regulation of endocytosis | 1.90e-02 | 1.00e+00 | 5.707 | 1 | 1 | 11 |
GO:1990090 | cellular response to nerve growth factor stimulus | 1.90e-02 | 1.00e+00 | 5.707 | 1 | 1 | 11 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.99e-02 | 1.00e+00 | 2.337 | 3 | 23 | 341 |
GO:0005739 | mitochondrion | 2.41e-02 | 1.00e+00 | 1.802 | 4 | 32 | 659 |
GO:0030552 | cAMP binding | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 1 | 14 |
GO:0050699 | WW domain binding | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 1 | 14 |
GO:0097194 | execution phase of apoptosis | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 4 | 15 |
GO:0016485 | protein processing | 2.75e-02 | 1.00e+00 | 5.166 | 1 | 1 | 16 |
GO:0005782 | peroxisomal matrix | 2.75e-02 | 1.00e+00 | 5.166 | 1 | 1 | 16 |
GO:0043022 | ribosome binding | 2.92e-02 | 1.00e+00 | 5.078 | 1 | 2 | 17 |
GO:0019933 | cAMP-mediated signaling | 2.92e-02 | 1.00e+00 | 5.078 | 1 | 1 | 17 |
GO:0031047 | gene silencing by RNA | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 2 | 18 |
GO:0006378 | mRNA polyadenylation | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 3 | 18 |
GO:0032320 | positive regulation of Ras GTPase activity | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 2 | 18 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 1 | 19 |
GO:2001235 | positive regulation of apoptotic signaling pathway | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 2 | 19 |
GO:0005720 | nuclear heterochromatin | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 3 | 20 |
GO:0034660 | ncRNA metabolic process | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 1 | 20 |
GO:0016071 | mRNA metabolic process | 3.45e-02 | 1.00e+00 | 2.757 | 2 | 10 | 170 |
GO:0048167 | regulation of synaptic plasticity | 3.60e-02 | 1.00e+00 | 4.774 | 1 | 1 | 21 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 3.60e-02 | 1.00e+00 | 4.774 | 1 | 2 | 21 |
GO:0051084 | 'de novo' posttranslational protein folding | 3.76e-02 | 1.00e+00 | 4.707 | 1 | 4 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 3.76e-02 | 1.00e+00 | 4.707 | 1 | 1 | 22 |
GO:0000049 | tRNA binding | 3.93e-02 | 1.00e+00 | 4.642 | 1 | 2 | 23 |
GO:0007162 | negative regulation of cell adhesion | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 2 | 24 |
GO:0006370 | 7-methylguanosine mRNA capping | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 5 | 24 |
GO:0016070 | RNA metabolic process | 4.15e-02 | 1.00e+00 | 2.611 | 2 | 10 | 188 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 4.27e-02 | 1.00e+00 | 4.522 | 1 | 3 | 25 |
GO:0030145 | manganese ion binding | 4.43e-02 | 1.00e+00 | 4.466 | 1 | 3 | 26 |
GO:0006418 | tRNA aminoacylation for protein translation | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 4 | 29 |
GO:0005778 | peroxisomal membrane | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 3 | 29 |
GO:0006446 | regulation of translational initiation | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 2 | 29 |
GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand | 5.27e-02 | 1.00e+00 | 4.212 | 1 | 1 | 31 |
GO:0001568 | blood vessel development | 5.27e-02 | 1.00e+00 | 4.212 | 1 | 1 | 31 |
GO:0071320 | cellular response to cAMP | 5.60e-02 | 1.00e+00 | 4.122 | 1 | 1 | 33 |
GO:0032092 | positive regulation of protein binding | 5.76e-02 | 1.00e+00 | 4.078 | 1 | 2 | 34 |
GO:0050434 | positive regulation of viral transcription | 5.93e-02 | 1.00e+00 | 4.037 | 1 | 5 | 35 |
GO:0044297 | cell body | 5.93e-02 | 1.00e+00 | 4.037 | 1 | 5 | 35 |
GO:0004197 | cysteine-type endopeptidase activity | 6.25e-02 | 1.00e+00 | 3.956 | 1 | 1 | 37 |
GO:0045860 | positive regulation of protein kinase activity | 6.25e-02 | 1.00e+00 | 3.956 | 1 | 2 | 37 |
GO:0005524 | ATP binding | 6.30e-02 | 1.00e+00 | 1.365 | 4 | 37 | 892 |
GO:0048511 | rhythmic process | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 5 | 38 |
GO:0010976 | positive regulation of neuron projection development | 6.58e-02 | 1.00e+00 | 3.881 | 1 | 1 | 39 |
GO:0043525 | positive regulation of neuron apoptotic process | 6.91e-02 | 1.00e+00 | 3.808 | 1 | 1 | 41 |
GO:0000775 | chromosome, centromeric region | 6.91e-02 | 1.00e+00 | 3.808 | 1 | 6 | 41 |
GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 2 | 42 |
GO:0005829 | cytosol | 7.42e-02 | 1.00e+00 | 0.948 | 6 | 88 | 1787 |
GO:0000151 | ubiquitin ligase complex | 8.04e-02 | 1.00e+00 | 3.581 | 1 | 4 | 48 |
GO:0005777 | peroxisome | 8.36e-02 | 1.00e+00 | 3.522 | 1 | 2 | 50 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 8.68e-02 | 1.00e+00 | 3.466 | 1 | 8 | 52 |
GO:0030165 | PDZ domain binding | 8.68e-02 | 1.00e+00 | 3.466 | 1 | 3 | 52 |
GO:0007218 | neuropeptide signaling pathway | 8.84e-02 | 1.00e+00 | 3.438 | 1 | 2 | 53 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 8.84e-02 | 1.00e+00 | 3.438 | 1 | 3 | 53 |
GO:0005770 | late endosome | 9.00e-02 | 1.00e+00 | 3.411 | 1 | 2 | 54 |
GO:0006338 | chromatin remodeling | 9.16e-02 | 1.00e+00 | 3.385 | 1 | 7 | 55 |
GO:0071260 | cellular response to mechanical stimulus | 9.16e-02 | 1.00e+00 | 3.385 | 1 | 2 | 55 |
GO:0031175 | neuron projection development | 9.16e-02 | 1.00e+00 | 3.385 | 1 | 1 | 55 |
GO:0000165 | MAPK cascade | 9.64e-02 | 1.00e+00 | 3.308 | 1 | 3 | 58 |
GO:0000785 | chromatin | 9.80e-02 | 1.00e+00 | 3.283 | 1 | 6 | 59 |
GO:0055114 | oxidation-reduction process | 9.88e-02 | 1.00e+00 | 1.899 | 2 | 9 | 308 |
GO:0016337 | single organismal cell-cell adhesion | 1.03e-01 | 1.00e+00 | 3.212 | 1 | 3 | 62 |
GO:0001764 | neuron migration | 1.11e-01 | 1.00e+00 | 3.100 | 1 | 1 | 67 |
GO:0051082 | unfolded protein binding | 1.15e-01 | 1.00e+00 | 3.037 | 1 | 5 | 70 |
GO:0044267 | cellular protein metabolic process | 1.24e-01 | 1.00e+00 | 1.707 | 2 | 14 | 352 |
GO:0071456 | cellular response to hypoxia | 1.24e-01 | 1.00e+00 | 2.918 | 1 | 2 | 76 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 1.24e-01 | 1.00e+00 | 2.918 | 1 | 1 | 76 |
GO:0042802 | identical protein binding | 1.25e-01 | 1.00e+00 | 1.698 | 2 | 15 | 354 |
GO:0008270 | zinc ion binding | 1.28e-01 | 1.00e+00 | 1.245 | 3 | 39 | 727 |
GO:0097190 | apoptotic signaling pathway | 1.35e-01 | 1.00e+00 | 2.791 | 1 | 1 | 83 |
GO:0045202 | synapse | 1.35e-01 | 1.00e+00 | 2.791 | 1 | 3 | 83 |
GO:0044255 | cellular lipid metabolic process | 1.44e-01 | 1.00e+00 | 2.690 | 1 | 2 | 89 |
GO:0030036 | actin cytoskeleton organization | 1.46e-01 | 1.00e+00 | 2.674 | 1 | 4 | 90 |
GO:0005737 | cytoplasm | 1.47e-01 | 1.00e+00 | 0.611 | 7 | 127 | 2633 |
GO:0006461 | protein complex assembly | 1.47e-01 | 1.00e+00 | 2.658 | 1 | 2 | 91 |
GO:0005506 | iron ion binding | 1.49e-01 | 1.00e+00 | 2.642 | 1 | 4 | 92 |
GO:0005730 | nucleolus | 1.53e-01 | 1.00e+00 | 0.917 | 4 | 74 | 1217 |
GO:0006457 | protein folding | 1.56e-01 | 1.00e+00 | 2.566 | 1 | 5 | 97 |
GO:0007568 | aging | 1.56e-01 | 1.00e+00 | 2.566 | 1 | 3 | 97 |
GO:0030335 | positive regulation of cell migration | 1.62e-01 | 1.00e+00 | 2.508 | 1 | 2 | 101 |
GO:0005911 | cell-cell junction | 1.67e-01 | 1.00e+00 | 2.466 | 1 | 3 | 104 |
GO:0016032 | viral process | 1.69e-01 | 1.00e+00 | 1.424 | 2 | 30 | 428 |
GO:0043005 | neuron projection | 1.80e-01 | 1.00e+00 | 2.346 | 1 | 6 | 113 |
GO:0000287 | magnesium ion binding | 1.83e-01 | 1.00e+00 | 2.320 | 1 | 4 | 115 |
GO:0007420 | brain development | 1.88e-01 | 1.00e+00 | 2.271 | 1 | 3 | 119 |
GO:0003924 | GTPase activity | 1.88e-01 | 1.00e+00 | 2.271 | 1 | 7 | 119 |
GO:0006974 | cellular response to DNA damage stimulus | 1.91e-01 | 1.00e+00 | 2.247 | 1 | 11 | 121 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.97e-01 | 1.00e+00 | 2.200 | 1 | 4 | 125 |
GO:0006184 | GTP catabolic process | 2.04e-01 | 1.00e+00 | 2.144 | 1 | 7 | 130 |
GO:0019904 | protein domain specific binding | 2.04e-01 | 1.00e+00 | 2.144 | 1 | 4 | 130 |
GO:0005622 | intracellular | 2.25e-01 | 1.00e+00 | 1.986 | 1 | 2 | 145 |
GO:0016874 | ligase activity | 2.26e-01 | 1.00e+00 | 1.976 | 1 | 11 | 146 |
GO:0004871 | signal transducer activity | 2.29e-01 | 1.00e+00 | 1.956 | 1 | 4 | 148 |
GO:0005874 | microtubule | 2.49e-01 | 1.00e+00 | 1.817 | 1 | 10 | 163 |
GO:0043025 | neuronal cell body | 2.60e-01 | 1.00e+00 | 1.748 | 1 | 3 | 171 |
GO:0007264 | small GTPase mediated signal transduction | 2.64e-01 | 1.00e+00 | 1.723 | 1 | 8 | 174 |
GO:0000166 | nucleotide binding | 2.66e-01 | 1.00e+00 | 1.707 | 1 | 13 | 176 |
GO:0006412 | translation | 2.69e-01 | 1.00e+00 | 1.690 | 1 | 12 | 178 |
GO:0004842 | ubiquitin-protein transferase activity | 2.70e-01 | 1.00e+00 | 1.682 | 1 | 17 | 179 |
GO:0016567 | protein ubiquitination | 2.82e-01 | 1.00e+00 | 1.611 | 1 | 14 | 188 |
GO:0005525 | GTP binding | 2.93e-01 | 1.00e+00 | 1.544 | 1 | 12 | 197 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.96e-01 | 1.00e+00 | 1.529 | 1 | 8 | 199 |
GO:0035556 | intracellular signal transduction | 2.96e-01 | 1.00e+00 | 1.529 | 1 | 5 | 199 |
GO:0043065 | positive regulation of apoptotic process | 2.99e-01 | 1.00e+00 | 1.508 | 1 | 7 | 202 |
GO:0015031 | protein transport | 3.01e-01 | 1.00e+00 | 1.501 | 1 | 10 | 203 |
GO:0030154 | cell differentiation | 3.02e-01 | 1.00e+00 | 1.494 | 1 | 5 | 204 |
GO:0043234 | protein complex | 3.09e-01 | 1.00e+00 | 1.452 | 1 | 13 | 210 |
GO:0019899 | enzyme binding | 3.09e-01 | 1.00e+00 | 1.452 | 1 | 7 | 210 |
GO:0043231 | intracellular membrane-bounded organelle | 3.19e-01 | 1.00e+00 | 1.398 | 1 | 8 | 218 |
GO:0007186 | G-protein coupled receptor signaling pathway | 3.32e-01 | 1.00e+00 | 1.327 | 1 | 4 | 229 |
GO:0019901 | protein kinase binding | 3.36e-01 | 1.00e+00 | 1.308 | 1 | 8 | 232 |
GO:0003682 | chromatin binding | 3.59e-01 | 1.00e+00 | 1.189 | 1 | 15 | 252 |
GO:0006508 | proteolysis | 3.73e-01 | 1.00e+00 | 1.122 | 1 | 11 | 264 |
GO:0008285 | negative regulation of cell proliferation | 3.87e-01 | 1.00e+00 | 1.052 | 1 | 11 | 277 |
GO:0009986 | cell surface | 4.02e-01 | 1.00e+00 | 0.981 | 1 | 5 | 291 |
GO:0003674 | molecular_function | 4.09e-01 | 1.00e+00 | 0.952 | 1 | 4 | 297 |
GO:0045892 | negative regulation of transcription, DNA-templated | 4.30e-01 | 1.00e+00 | 0.858 | 1 | 17 | 317 |
GO:0048471 | perinuclear region of cytoplasm | 4.57e-01 | 1.00e+00 | 0.740 | 1 | 11 | 344 |
GO:0005509 | calcium ion binding | 4.64e-01 | 1.00e+00 | 0.711 | 1 | 9 | 351 |
GO:0005783 | endoplasmic reticulum | 4.92e-01 | 1.00e+00 | 0.592 | 1 | 12 | 381 |
GO:0006915 | apoptotic process | 5.19e-01 | 1.00e+00 | 0.483 | 1 | 15 | 411 |
GO:0005634 | nucleus | 5.19e-01 | 1.00e+00 | 0.086 | 6 | 158 | 3246 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 5.57e-01 | 1.00e+00 | 0.333 | 1 | 29 | 456 |
GO:0005887 | integral component of plasma membrane | 6.44e-01 | 1.00e+00 | -0.001 | 1 | 8 | 575 |
GO:0044281 | small molecule metabolic process | 7.85e-01 | 1.00e+00 | -0.555 | 1 | 35 | 844 |
GO:0046872 | metal ion binding | 8.19e-01 | 1.00e+00 | -0.701 | 1 | 24 | 934 |
GO:0003677 | DNA binding | 8.24e-01 | 1.00e+00 | -0.721 | 1 | 52 | 947 |
GO:0005886 | plasma membrane | 8.45e-01 | 1.00e+00 | -0.635 | 2 | 46 | 1784 |
GO:0006351 | transcription, DNA-templated | 8.63e-01 | 1.00e+00 | -0.906 | 1 | 47 | 1076 |
GO:0070062 | extracellular vesicular exosome | 9.56e-01 | 1.00e+00 | -1.514 | 1 | 51 | 1641 |